Lethal congenital contracture syndrome type 2

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Mar 2024Study of JK07 in Patients With Chronic Heart Failure

Salubris Biotherapeutics Inc — PHASE2

TrialRECRUITING
Feb 2024Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers

Hummingbird Bioscience — PHASE1, PHASE2

TrialRECRUITING
Oct 2017Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

M.D. Anderson Cancer Center — PHASE1

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Lethal congenital contracture syndrome type 2.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Lethal congenital contracture syndrome type 2.
Search all trials →
Search clinical trials for Lethal congenital contracture syndrome type 2

Recent News & Research

No recent news articles indexed yet for Lethal congenital contracture syndrome type 2.
Search PubMed for Lethal congenital contracture syndrome type 2

Browse all Lethal congenital contracture syndrome type 2 news →

Specialist Network

Top 3 by expertise

View all Lethal congenital contracture syndrome type 2 specialists →

Quick Actions